<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK7041" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK7041/" /><meta name="ncbi_pagename" content="Microphthalmia with Linear Skin Defects Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Microphthalmia with Linear Skin Defects Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Microphthalmia with Linear Skin Defects Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/07/26" /><meta name="citation_author" content="Manuela Morleo" /><meta name="citation_author" content="Brunella Franco" /><meta name="citation_pmid" content="20301767" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK7041/" /><meta name="citation_keywords" content="Microphthalmia, Dermal Aplasia, and Sclerocornea (MIDAS) Syndrome" /><meta name="citation_keywords" content="MLS Syndrome" /><meta name="citation_keywords" content="MLS Syndrome" /><meta name="citation_keywords" content="Microphthalmia, Dermal Aplasia, and Sclerocornea Syndrome" /><meta name="citation_keywords" content="Cytochrome c oxidase subunit 7B, mitochondrial" /><meta name="citation_keywords" content="Cytochrome c-type heme lyase" /><meta name="citation_keywords" content="NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial" /><meta name="citation_keywords" content="COX7B" /><meta name="citation_keywords" content="HCCS" /><meta name="citation_keywords" content="NDUFB11" /><meta name="citation_keywords" content="Microphthalmia with Linear Skin Defects Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Microphthalmia with Linear Skin Defects Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Manuela Morleo" /><meta name="DC.Contributor" content="Brunella Franco" /><meta name="DC.Date" content="2018/07/26" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK7041/" /><meta name="description" content="Microphthalmia with linear skin defects (MLS) syndrome is characterized by unilateral or bilateral microphthalmia and/or anophthalmia and linear skin defects, usually involving the face and neck, which are present at birth and heal with age, leaving minimal residual scarring. Other findings can include a wide variety of other ocular abnormalities (e.g., corneal anomalies, orbital cysts, cataracts), central nervous system involvement (e.g., structural anomalies, developmental delay, infantile seizures), cardiac concerns (e.g., hypertrophic or oncocytic cardiomyopathy, atrial or ventricular septal defects, arrhythmias), short stature, diaphragmatic hernia, nail dystrophy, hearing impairment, and genitourinary malformations. Inter- and intrafamilial variability is described." /><meta name="og:title" content="Microphthalmia with Linear Skin Defects Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Microphthalmia with linear skin defects (MLS) syndrome is characterized by unilateral or bilateral microphthalmia and/or anophthalmia and linear skin defects, usually involving the face and neck, which are present at birth and heal with age, leaving minimal residual scarring. Other findings can include a wide variety of other ocular abnormalities (e.g., corneal anomalies, orbital cysts, cataracts), central nervous system involvement (e.g., structural anomalies, developmental delay, infantile seizures), cardiac concerns (e.g., hypertrophic or oncocytic cardiomyopathy, atrial or ventricular septal defects, arrhythmias), short stature, diaphragmatic hernia, nail dystrophy, hearing impairment, and genitourinary malformations. Inter- and intrafamilial variability is described." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK7041/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/microph-lsd/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK7041/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D1B67DFC88DC100000000039901B1.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK7041_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK7041_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/miccap-ms/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/anophthalmia-ov/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK7041_"><span class="title" itemprop="name">Microphthalmia with Linear Skin Defects Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Microphthalmia, Dermal Aplasia, and Sclerocornea (MIDAS) Syndrome; MLS Syndrome</div><p class="contrib-group"><span itemprop="author">Manuela Morleo</span>, PhD and <span itemprop="author">Brunella Franco</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK7041_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK7041_ai__"><div class="contrib half_rhythm"><span itemprop="author">Manuela Morleo</span>, PhD<div class="affiliation small">Telethon Institute of Genetics and Medicine (TIGEM)<br />Department of Translational Medicine<br />Federico II University<br />Naples, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.megit@oelrom" class="oemail">ti.megit@oelrom</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Brunella Franco</span>, MD<div class="affiliation small">Telethon Institute of Genetics and Medicine (TIGEM)<br />Department of Translational Medicine<br />Federico II University<br />Naples, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.megit@ocnarf" class="oemail">ti.megit@ocnarf</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 18, 2009</span>; Last Update: <span itemprop="dateModified">July 26, 2018</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="microph-lsd.Summary" itemprop="description"><h2 id="_microph-lsd_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Microphthalmia with linear skin defects (MLS) syndrome is characterized by unilateral or bilateral microphthalmia and/or anophthalmia and linear skin defects, usually involving the face and neck, which are present at birth and heal with age, leaving minimal residual scarring. Other findings can include a wide variety of other ocular abnormalities (e.g., corneal anomalies, orbital cysts, cataracts), central nervous system involvement (e.g., structural anomalies, developmental delay, infantile seizures), cardiac concerns (e.g., hypertrophic or oncocytic cardiomyopathy, atrial or ventricular septal defects, arrhythmias), short stature, diaphragmatic hernia, nail dystrophy, hearing impairment, and genitourinary malformations. Inter- and <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> is described.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The clinical diagnosis is established when the two major criteria (microphthalmia and/or anophthalmia <i>and</i> linear skin defects) are present and confirmed by identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COX7B</i>, <i>HCCS</i>, or <i>NDUFB11</i>. However, persons with a molecular diagnosis of MLS syndrome in whom only one of the two major criteria was present have been reported: some show characteristic skin defects without ocular abnormalities and others show eye abnormalities without skin defects.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Use of a prosthesis under the guidance of an oculoplastics specialist for severe microphthalmia and anophthalmia; routine dermatologic care for significant skin lesions; treatment of seizures and/or other neurologic abnormalities by a pediatric neurologist; appropriate developmental therapies and special education as indicated for developmental delay and intellectual disability; routine care for other medical concerns when present.</p><p><i>Surveillance:</i> Monitoring and follow up with ophthalmologist, dermatologist, pediatric neurologist, cardiologist, and other professionals as needed.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>MLS syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner and is generally lethal in males. Most cases are <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> (i.e., a single occurrence in a family), but rare <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> occurrences have been described. Women who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or have an MLS syndrome-associated <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of passing the genetic alteration to each offspring. Because male conceptuses with an MLS syndrome-associated pathogenic variant are typically nonviable, the likelihood of a live-born affected child is less than 50%. Molecular genetic testing of at-risk female relatives to determine their genetic status, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for MLS syndrome are each possible if the disease-causing genetic alteration has been identified in an affected family member.</p></div></div><div id="microph-lsd.Diagnosis"><h2 id="_microph-lsd_Diagnosis_">Diagnosis</h2><div id="microph-lsd.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Microphthalmia with linear skin defects (MLS) syndrome <b>should be suspected</b> in females with one or both major criteria especially in the presence of a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance with male lethality (see <a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F1/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF1" rid-ob="figobmicrophlsdF1">Figures 1</a>, <a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F2/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF2" rid-ob="figobmicrophlsdF2">2</a>, and <a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F3/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF3" rid-ob="figobmicrophlsdF3">3</a>). Almost all individuals with MLS syndrome are female; however, a few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males, typically with an XX <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>, have been reported.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmicrophlsdF1" co-legend-rid="figlgndmicrophlsdF1"><a href="/books/NBK7041/figure/microph-lsd.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figmicrophlsdF1" rid-ob="figobmicrophlsdF1"><img class="small-thumb" src="/books/NBK7041/bin/microph-lsd-Image001.gif" src-large="/books/NBK7041/bin/microph-lsd-Image001.jpg" alt="Figure 1. . Reticulolinear scar lesions on the neck of a female age 36 years with an otherwise normal phenotype." /></a><div class="icnblk_cntnt" id="figlgndmicrophlsdF1"><h4 id="microph-lsd.F1"><a href="/books/NBK7041/figure/microph-lsd.F1/?report=objectonly" target="object" rid-ob="figobmicrophlsdF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Reticulolinear scar lesions on the neck of a female age 36 years with an otherwise normal phenotype. Cytogenetic analysis revealed 46,X,del(X)(p22.3 pter) [Lindsay et al 1994].</p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmicrophlsdF2" co-legend-rid="figlgndmicrophlsdF2"><a href="/books/NBK7041/figure/microph-lsd.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figmicrophlsdF2" rid-ob="figobmicrophlsdF2"><img class="small-thumb" src="/books/NBK7041/bin/microph-lsd-Image002.gif" src-large="/books/NBK7041/bin/microph-lsd-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndmicrophlsdF2"><h4 id="microph-lsd.F2"><a href="/books/NBK7041/figure/microph-lsd.F2/?report=objectonly" target="object" rid-ob="figobmicrophlsdF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Bilateral microphthalmia and irregular linear skin areas involving the face and neck in a female infant with MLS syndrome who has a single-nucleotide variant in exon 6 of <i>HCCS</i> [Wimplinger et al 2006] </p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmicrophlsdF3" co-legend-rid="figlgndmicrophlsdF3"><a href="/books/NBK7041/figure/microph-lsd.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figmicrophlsdF3" rid-ob="figobmicrophlsdF3"><img class="small-thumb" src="/books/NBK7041/bin/microph-lsd-Image003.gif" src-large="/books/NBK7041/bin/microph-lsd-Image003.jpg" alt="Figure 3. " /></a><div class="icnblk_cntnt" id="figlgndmicrophlsdF3"><h4 id="microph-lsd.F3"><a href="/books/NBK7041/figure/microph-lsd.F3/?report=objectonly" target="object" rid-ob="figobmicrophlsdF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Typical linear skin lesions on the face and neck of a newborn female with MLS syndrome who has a deletion of exons 1-3 of <i>HCCS</i> [Morleo et al 2005, Wimplinger et al 2006] </p></div></div><div id="microph-lsd.Major_Criteria"><h4>Major Criteria</h4><ul><li class="half_rhythm"><div>Microphthalmia and/or anophthalmia</div><ul><li class="half_rhythm"><div>Reported in 81% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>Can be unilateral or bilateral (see <a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F2/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF2" rid-ob="figobmicrophlsdF2">Figure 2</a>)</div></li></ul></li><li class="half_rhythm"><div>Linear skin defects</div><ul><li class="half_rhythm"><div>Reported in 75% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>Present at birth</div></li><li class="half_rhythm"><div>Usually involve the face and neck (see <a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F3/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF3" rid-ob="figobmicrophlsdF3">Figure 3</a>), although the scalp and occasionally the upper trunk may be involved [<a class="bk_pop" href="#microph-lsd.REF.zvulunov.1998.1046">Zvulunov et al 1998</a>]</div></li><li class="half_rhythm"><div>Heal with age, leaving minimal residual scarring</div></li></ul></li></ul></div></div><div id="microph-lsd.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The clinical signs observed in MLS syndrome are considered major if they are present in at least 70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and minor if they are less frequent (see Clinical Description, <a href="#microph-lsd.Minor_Criteria_in__70_of_aff">Minor Criteria</a>).</p><p>The clinical diagnosis of MLS syndrome can be made when the two major criteria are present [<a class="bk_pop" href="#microph-lsd.REF.algazali.1990.59">al-Gazali et al 1990</a>, <a class="bk_pop" href="#microph-lsd.REF.happle.1993.710">Happle et al 1993</a>]; however, persons with a molecular diagnosis of MLS syndrome in whom only one of the two major criteria was present have been reported: some show characteristic skin defects without ocular abnormalities (see <a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F1/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF1" rid-ob="figobmicrophlsdF1">Figure 1</a>); others show eye abnormalities without skin defects [<a class="bk_pop" href="#microph-lsd.REF.morleo.2008.401">Morleo &#x00026; Franco 2008</a>].</p><p><a href="#microph-lsd.Minor_Criteria_in__70_of_aff">Minor criteria</a> in the presence of a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance with male lethality supports the clinical diagnosis of MLS syndrome.</p><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of MLS syndrome <b>is established</b> in a female proband by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COX7B</i>, <i>HCCS</i>, or <i>NDUFB11</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK7041/table/microph-lsd.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figmicrophlsdTmoleculargenetictesting" rid-ob="figobmicrophlsdTmoleculargenetictesting">Table 1</a>).</p><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of MLS syndrome <b>is established</b> in a male proband by identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COX7B</i>, <i>HCCS</i>, or <i>NDUFB11</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK7041/table/microph-lsd.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figmicrophlsdTmoleculargenetictesting" rid-ob="figobmicrophlsdTmoleculargenetictesting">Table 1</a>).</p><p>Molecular testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis, <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of MLS syndrome is broad, individuals with both <a href="#microph-lsd.Major_Criteria">major criteria</a> are likely to be diagnosed using gene-targeted testing (see <a href="#microph-lsd.Option_1">Option 1</a>), whereas those in whom the diagnosis of MLS syndrome has not been considered due to atypical findings are more likely to be diagnosed using genomic testing (see <a href="#microph-lsd.Option_2">Option 2</a>).</p><div id="microph-lsd.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of MLS syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> microarray analysis or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Chromosomal microarray analysis (CMA</b>)<b>.</b> CMA should be the first genetic test as about 90% of MLS syndrome is caused by large copy number variants (CNVs), which cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>HCCS</i>.</div><div class="half_rhythm">Note: (1) Deletions reported in the literature were most frequently detected by <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> and <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis; however, CMA is used more frequently than karyotyping in clinical practice for individuals with complex medical issues and has greater resolution and precision than a karyotype. Some complex karyotypes have been reported (e.g., 45,X[18]/46,X,der(X)(p22q21)[24]/46,X,del(X)(p22)[58] and 46,X,der(X)t(X;Y)); therefore, karyotype and/or FISH follow up may be necessary based on CMA results. (2) Apparently balanced translocations have been reported in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#microph-lsd.REF.vergult.2013.311">Vergult et al 2013</a>]. In an affected person in whom other testing does not reveal a causative variant, karyotype analysis may be considered.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>COX7B</i>, <i>HCCS</i>, <i>NDUFB11</i>, and other genes of interest (see <a href="#microph-lsd.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition (if CMA is not diagnostic) at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK7041/table/microph-lsd.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figmicrophlsdTmoleculargenetictesting" rid-ob="figobmicrophlsdTmoleculargenetictesting">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="microph-lsd.Option_2"><h4>Option 2</h4><p>When the diagnosis of MLS syndrome is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is often performed. MLS syndrome is likely to be diagnosed by <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> microarray (CMA), which is the best first test when multiple <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> abnormalities are present. If CMA is not diagnostic, additional genomic testing is indicated. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if CMA and <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> are non-diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p>Note: Although not used for diagnosis, <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> studies have been performed in females with MLS syndrome. Skewed X-chromosome inactivation has been detected in 21 of the 22 individuals with MLS syndrome analyzed to date [<a class="bk_pop" href="#microph-lsd.REF.anguiano.2003.47">Anguiano et al 2003</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2006.878">Wimplinger et al 2006</a>, <a class="bk_pop" href="#microph-lsd.REF.cain.2007.373">Cain et al 2007</a>, <a class="bk_pop" href="#microph-lsd.REF.schluth.2007.29">Schluth et al 2007</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2007a.421">Wimplinger et al 2007a</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2007b.1475">Wimplinger et al 2007b</a>, <a class="bk_pop" href="#microph-lsd.REF.hobson.2009.1698">Hobson et al 2009</a>, <a class="bk_pop" href="#microph-lsd.REF.steichengersdorf.2010.82">Steichen-Gersdorf et al 2010</a>, <a class="bk_pop" href="#microph-lsd.REF.alberry.2011.111">Alberry et al 2011</a>]. In all individuals the abnormal X is inactive.</p><div id="microph-lsd.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in MLS syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7041/table/microph-lsd.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__microph-lsd.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of MLS Syndrome Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by This Method</th></tr><tr><th headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3" id="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4,&#x000a0;5</sup></th><th headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3" id="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></th><th headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3" id="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>7,&#x000a0;8,&#x000a0;9</sup></th></tr></thead><tbody><tr><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COX7B</i></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%&#x000a0;<sup>10</sup></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3 hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/3&#x000a0;<sup>11</sup></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3 hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>12</sup></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3 hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td></tr><tr><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HCCS</i></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~92%&#x000a0;<sup>10</sup></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3 hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~8%&#x000a0;<sup>13</sup></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3 hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 14</td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3 hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~92%&#x000a0;<sup>15,&#x000a0;16</sup></td></tr><tr><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NDUFB11</i></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~3%&#x000a0;<sup>10</sup></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3 hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/2&#x000a0;<sup>10</sup></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3 hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>12</sup></td><td headers="hd_h_microph-lsd.T.molecular_genetic_testing_1_1_1_3 hd_h_microph-lsd.T.molecular_genetic_testing_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="microph-lsd.TF.1.1"><p class="no_margin">Genes are listed alphabetically.</p></div></dd><dt>2. </dt><dd><div id="microph-lsd.TF.1.2"><p class="no_margin">See <a href="/books/NBK7041/#microph-lsd.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="microph-lsd.TF.1.3"><p class="no_margin">See <a href="#microph-lsd.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="microph-lsd.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="microph-lsd.TF.1.5"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>6. </dt><dd><div id="microph-lsd.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="microph-lsd.TF.1.7"><p class="no_margin">ClinGen: <a href="https://www.ncbi.nlm.nih.gov/projects/dbvar/clingen/clingen_gene.cgi?sym=hccs&#x00026;subject=" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ISCA-20454</a>. Standardized clinical annotation and interpretation for <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> variants from the <a href="http://www.clinicalgenome.org/about/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Clinical Genome Resource (ClinGen) project</a> (formerly the International Standards for Cytogenomic Arrays [ISCA] Consortium)</p></div></dd><dt>8. </dt><dd><div id="microph-lsd.TF.1.8"><p class="no_margin">Chromosomal microarray analysis (CMA) using oligonucleotide arrays or SNP arrays. CMA designs in current clinical use target the Xp22.3 region.</p></div></dd><dt>9. </dt><dd><div id="microph-lsd.TF.1.9"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing will detect deletions ranging from a single <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> to the whole <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>; however, breakpoints of large deletions and/or deletion of adjacent genes may not be detected by these methods.</p></div></dd><dt>10. </dt><dd><div id="microph-lsd.TF.1.10"><p class="no_margin"><a class="bk_pop" href="#microph-lsd.REF.van_rahden.2015.640">van Rahden et al [2015]</a></p></div></dd><dt>11. </dt><dd><div id="microph-lsd.TF.1.11"><p class="no_margin"><a class="bk_pop" href="#microph-lsd.REF.indrieri.2012.942">Indrieri et al [2012]</a></p></div></dd><dt>12. </dt><dd><div id="microph-lsd.TF.1.12"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>13. </dt><dd><div id="microph-lsd.TF.1.13"><p class="no_margin"><a class="bk_pop" href="#microph-lsd.REF.vergult.2013.311">Vergult et al [2013]</a>, <a class="bk_pop" href="#microph-lsd.REF.van_rahden.2014.53">van Rahden et al [2014]</a></p></div></dd><dt>14. </dt><dd><div id="microph-lsd.TF.1.14"><p class="no_margin">All large deletions reported to date are large deletions that encompass <i>HCCS</i> and surrounding sequence. Gene-targeted methods will detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> up to whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions; however, breakpoints of large deletions and/or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of adjacent genes may not be detected. Thus, the detection rate for <i>HCCS</i>-targeted deletion assays would be ~92%; however, the deletion may not be fully characterized.</p></div></dd><dt>15. </dt><dd><div id="microph-lsd.TF.1.15"><p class="no_margin"><a class="bk_pop" href="#microph-lsd.REF.vergult.2013.311">Vergult et al [2013]</a>, <a class="bk_pop" href="#microph-lsd.REF.van_rahden.2014.53">van Rahden et al [2014]</a></p></div></dd><dt>16. </dt><dd><div id="microph-lsd.TF.1.16"><p class="no_margin">Note: Deletions reported in the literature were most frequently detected by <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> and <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis; however, CMA is more commonly used than karyotyping in clinical practice for individuals with complex medical issues and has greater resolution and precision than a karyotype. Some complex karyotypes have been reported (e.g., 45,X[18]/46,X,der(X)(p22q21)[24]/46,X,del(X)(p22)[58] and 46,X,der(X)t(X;Y)), therefore, karyotype and/or FISH follow up may be necessary based on CMA results.</p></div></dd></dl></div></div></div></div></div></div><div id="microph-lsd.Clinical_Characteristics"><h2 id="_microph-lsd_Clinical_Characteristics_">Clinical Characteristics</h2><div id="microph-lsd.Clinical_Description"><h3>Clinical Description</h3><p>Microphthalmia with linear skin defects (MLS) syndrome is characterized by unilateral or bilateral microphthalmia or anophthalmia (see <a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F2/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF2" rid-ob="figobmicrophlsdF2">Figure 2</a>) and/or jagged skin defects on the face and neck (see <a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F3/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF3" rid-ob="figobmicrophlsdF3">Figure 3</a>). MLS syndrome is usually lethal in males [<a class="bk_pop" href="#microph-lsd.REF.kono.1999.63">Kono et al 1999</a>, <a class="bk_pop" href="#microph-lsd.REF.kherbaouiredouani.2003.224">Kherbaoui-Redouani et al 2003</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2006.878">Wimplinger et al 2006</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2007a.421">Wimplinger et al 2007a</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2007b.1475">Wimplinger et al 2007b</a>, <a class="bk_pop" href="#microph-lsd.REF.kapur.2008.734">Kapur et al 2008</a>, <a class="bk_pop" href="#microph-lsd.REF.sharma.2008.548">Sharma et al 2008</a>, <a class="bk_pop" href="#microph-lsd.REF.hobson.2009.1698">Hobson et al 2009</a>, <a class="bk_pop" href="#microph-lsd.REF.steichengersdorf.2010.82">Steichen-Gersdorf et al 2010</a>, <a class="bk_pop" href="#microph-lsd.REF.alberry.2011.111">Alberry et al 2011</a>].</p><p><b>Phenotypic variability.</b> Inter- and intrafamilial phenotypic variability has been described. The manifestations differ among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and, although most display the classic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of MLS syndrome, many have only a subset of characteristic features: some show the characteristic skin defects without ocular abnormalities, whereas others have eye abnormalities without skin defects [<a class="bk_pop" href="#microph-lsd.REF.morleo.2008.401">Morleo &#x00026; Franco 2008</a>]. For example, a female with a normal phenotype except for typical MLS syndrome skin defects (see <a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F1/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF1" rid-ob="figobmicrophlsdF1">Figure 1</a>) had an affected female fetus with anencephaly.</p><div id="microph-lsd.Major_Criteria_1"><h4>Major Criteria</h4><p><b>Eye findings.</b> Microphthalmia and/or anophthalmia, when present, are evident at birth in 81% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (<a class="figpopup" href="/books/NBK7041/figure/microph-lsd.F2/?report=objectonly" target="object" rid-figpopup="figmicrophlsdF2" rid-ob="figobmicrophlsdF2">Figure 2</a>). Both microphthalmia and anophthalmia can be unilateral or bilateral.</p><p><b>Skin manifestations.</b> In general, no new lesions are observed after birth and the skin defects heal variably with age, leaving minimal residual scarring. The cutaneous findings typically follow the lines of Blaschko corresponding to cell migration pathways evident during embryonic and fetal skin development, which (unlike dermatomes) do not correspond to innervation patterns. The restriction to the head and neck is thought to result from involvement of neural crest cells [<a class="bk_pop" href="#microph-lsd.REF.algazali.1990.59">al-Gazali et al 1990</a>, <a class="bk_pop" href="#microph-lsd.REF.lindsay.1994.229">Lindsay et al 1994</a>].</p><p><b>Histologic skin findings.</b>
<a class="bk_pop" href="#microph-lsd.REF.happle.1993.710">Happle et al [1993]</a> coined the acronym MIDAS (for <i>mi</i>crophthalmia, <i>d</i>ermal <i>a</i>plasia, and <i>s</i>clerocornea), and argued that (in contrast to <a href="/books/n/gene/focal-dh/">focal dermal hypoplasia</a>) the erythematous lesions of dermal aplasia do not show herniation of fatty tissue. Subsequent histologic examination of skin biopsies of the linear, reticulated skin defects in six reported individuals yielded varied results, all confirming that dermal aplasia is not a histologic feature of MLS syndrome [<a class="bk_pop" href="#microph-lsd.REF.bird.1994.141">Bird et al 1994</a>, <a class="bk_pop" href="#microph-lsd.REF.eng.1994.680">Eng et al 1994</a>, <a class="bk_pop" href="#microph-lsd.REF.paulger.1997.26">Paulger et al 1997</a>, <a class="bk_pop" href="#microph-lsd.REF.stratton.1998.37">Stratton et al 1998</a>, <a class="bk_pop" href="#microph-lsd.REF.zvulunov.1998.1046">Zvulunov et al 1998</a>, <a class="bk_pop" href="#microph-lsd.REF.enright.2003.153">Enright et al 2003</a>].</p></div><div id="microph-lsd.Minor_Criteria_in__70_of_aff"><h4>Minor Criteria (in &#x0003c;70% of affected individuals)</h4><p>Note: Categories are in descending order of frequency.</p><p><b>Other ocular abnormalities</b>
<b>reported</b> [<a class="bk_pop" href="#microph-lsd.REF.kobayashi.1998.122">Kobayashi et al 1998</a>, <a class="bk_pop" href="#microph-lsd.REF.cape.2004.1070">Cape et al 2004</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2006.878">Wimplinger et al 2006</a>, <a class="bk_pop" href="#microph-lsd.REF.kapur.2008.734">Kapur et al 2008</a>, <a class="bk_pop" href="#microph-lsd.REF.carman.2009.234">Carman et al 2009</a>, <a class="bk_pop" href="#microph-lsd.REF.garc_arabasco.2013.e230">Garc&#x000ed;a-Rabasco et al 2013</a>, <a class="bk_pop" href="#microph-lsd.REF.vergult.2013.311">Vergult et al 2013</a>, <a class="bk_pop" href="#microph-lsd.REF.herwig.2014.491">Herwig et al 2014</a>, <a class="bk_pop" href="#microph-lsd.REF.van_rahden.2014.53">van Rahden et al 2014</a>, <a class="bk_pop" href="#microph-lsd.REF.van_rahden.2015.640">van Rahden et al 2015</a>]:</p><ul><li class="half_rhythm"><div>Sclerocornea</div></li><li class="half_rhythm"><div>Orbital cysts</div></li><li class="half_rhythm"><div>Microcornea</div></li><li class="half_rhythm"><div>Eyelid fissures</div></li><li class="half_rhythm"><div>Corneal leukoma</div></li><li class="half_rhythm"><div>Iridocorneal adhesion (Peters anomaly)</div></li><li class="half_rhythm"><div>Congenital glaucoma with total/peripheral anterior synechiae</div></li><li class="half_rhythm"><div>Aniridia</div></li><li class="half_rhythm"><div>Cataracts</div></li><li class="half_rhythm"><div>A remnant of the anterior hyaloid artery</div></li><li class="half_rhythm"><div>Vitreous opacity</div></li><li class="half_rhythm"><div>Hypopigmented areas of the retinal pigment epithelium</div></li></ul><p><b>Central nervous system</b>
<b>involvement</b></p><ul><li class="half_rhythm"><div>Agenesis of corpus callosum</div></li><li class="half_rhythm"><div>Anencephaly</div></li><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Hydrocephalus</div></li><li class="half_rhythm"><div>Developmental delay / intellectual disability</div></li><li class="half_rhythm"><div>Infantile seizures</div></li></ul><p><b>Cardiac concerns</b></p><ul><li class="half_rhythm"><div>Cardiomyopathy (hypertrophic or oncocytic)</div></li><li class="half_rhythm"><div>Atrial and ventricular septal defects</div></li><li class="half_rhythm"><div>Arrhythmias such as supraventricular tachycardia and ventricular fibrillation</div></li></ul><p><b>Other reported findings (including frequency)</b></p><ul><li class="half_rhythm"><div>Short stature (18/42)</div></li><li class="half_rhythm"><div>Genitourinary or lower intestinal malformations: bicornuate uterus, ambiguous genitalia, anterior or imperforate anus, penile hypospadias in rare males with a 46,XX <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> (14/64)</div></li><li class="half_rhythm"><div>Hearing impairment (5/64)</div></li><li class="half_rhythm"><div>Nail dystrophy (3/55)</div></li><li class="half_rhythm"><div>Diaphragmatic hernia (3/64)</div></li><li class="half_rhythm"><div>Pseudotail [<a class="bk_pop" href="#microph-lsd.REF.alberry.2011.111">Alberry et al 2011</a>]; as a single case report. This may be a coincidental finding and not typical of MLS syndrome.</div></li></ul></div></div><div id="microph-lsd.GenotypePhenotype_Correlatio"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been observed.</p></div><div id="microph-lsd.Nomenclature"><h3>Nomenclature</h3><p>MLS syndrome, first described by <a class="bk_pop" href="#microph-lsd.REF.algazali.1990.59">al-Gazali et al [1990]</a>, was initially known as Gazali-Temple syndrome.</p><p>MLS syndrome appears to be the most appropriate designation for this disorder.</p><p><a class="bk_pop" href="#microph-lsd.REF.happle.1993.710">Happle et al [1993]</a> coined the acronym MIDAS (for <i>mi</i>crophthalmia, <i>d</i>ermal <i>a</i>plasia, and <i>s</i>clerocornea) for what is now known as MLS syndrome.</p></div><div id="microph-lsd.Prevalence"><h3>Prevalence</h3><p>The disorder is rare; 64 individuals with a clinical diagnosis of MLS syndrome have been reported to date.</p></div></div><div id="microph-lsd.Genetically_Related_Allelic"><h2 id="_microph-lsd_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>COX7B</i> or <i>HCCS.</i></p><p><i>NDUFB11</i> pathogenic variants have recently been associated with histiocytoid cardiomyopathy [<a class="bk_pop" href="#microph-lsd.REF.shehata.2015.2114">Shehata et al 2015</a>, <a class="bk_pop" href="#microph-lsd.REF.rea.2017.a001271">Rea et al 2017</a>] and sideroblastic anemia [<a class="bk_pop" href="#microph-lsd.REF.torraco.2017.441">Torraco et al 2017</a>].</p></div><div id="microph-lsd.Differential_Diagnosis"><h2 id="_microph-lsd_Differential_Diagnosis_">Differential Diagnosis</h2><div id="microph-lsd.T.disorders_to_consider_in_t" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of MLS Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7041/table/microph-lsd.T.disorders_to_consider_in_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__microph-lsd.T.disorders_to_consider_in_t_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features</th></tr><tr><th headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4" id="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping</th><th headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4" id="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing</th></tr></thead><tbody><tr><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/focal-dh/">Focal dermal hypoplasia</a><br />(Goltz syndrome)</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PORCN</i></td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4 hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Distinctive skin findings (dermal hypoplasia)</div></li><li class="half_rhythm"><div>Ophthalmologic manifestations</div></li></ul>
</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4 hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In focal dermal hypoplasia:<br />Limb &#x00026; skeletal malformations</td></tr><tr><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/i-p/">Incontinentia pigmenti</a> (IP)</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IKBKG</i><br />(<i>NEMO</i>)</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4 hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Skin lesions</div></li><li class="half_rhythm"><div>Ocular abnormalities (present in 35% of individuals w/IP diagnosis)</div></li></ul>
</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4 hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In incontinentia pigmenti:
<ul><li class="half_rhythm"><div>Erythema followed by blisters (vesicles) anywhere on the body</div></li><li class="half_rhythm"><div>Verrucous lesions</div></li></ul>
</td></tr><tr><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oculocerebro-<br />cutaneous syndrome (OCCS)<br />(OMIM <a href="https://omim.org/entry/164180" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">164180</a>)</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">?</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">?</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4 hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Focal skin defects</div></li><li class="half_rhythm"><div>Anophthalmia / microphthalmia</div></li></ul>
</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4 hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In OCCS:
<ul><li class="half_rhythm"><div>Observed in males prevalently&#x000a0;<sup>1</sup></div></li><li class="half_rhythm"><div>Brain malformation&#x000a0;<sup>2</sup></div></li><li class="half_rhythm"><div>Psychomotor impairment &#x00026; episodes of seizures</div></li></ul>
</td></tr><tr><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/aic/">Aicardi syndrome</a></td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">?</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4 hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Microphthalmia</div></li><li class="half_rhythm"><div>Pigmentary lesions of the skin</div></li></ul>
</td><td headers="hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_1_4 hd_h_microph-lsd.T.disorders_to_consider_in_t_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In Aicardi syndrome:&#x000a0;<sup>3</sup>
<ul><li class="half_rhythm"><div>Agenesis of the corpus callosum</div></li><li class="half_rhythm"><div>Distinctive chorioretinal lacunae</div></li><li class="half_rhythm"><div>Infantile spasms</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt></dt><dd><div><p class="no_margin">? = unknown</p></div></dd><dt>1. </dt><dd><div id="microph-lsd.TF.2.1"><p class="no_margin">MLS syndrome is male lethal.</p></div></dd><dt>2. </dt><dd><div id="microph-lsd.TF.2.2"><p class="no_margin">Polymicrogyria or periventricular heterotopia, agenesis of the corpus callosum, hypoplastic vermis of the cerebellum, hydrocephalus</p></div></dd><dt>3. </dt><dd><div id="microph-lsd.TF.2.3"><p class="no_margin">Two of the three classic features (agenesis of the corpus callosum, distinctive chorioretinal lacunae, infantile spasms) are needed to make the diagnosis of Aicardi syndrome; these features are rarely found associated with microphthalmia in MLS syndrome.</p></div></dd></dl></div></div></div></div><div id="microph-lsd.Management"><h2 id="_microph-lsd_Management_">Management</h2><div id="microph-lsd.Evaluations_Following_Initia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with microphthalmia with linear skin lesions (MLS) syndrome, the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Ophthalmologic examination</div></li><li class="half_rhythm"><div>Dermatologic evaluation for skin lesions</div></li><li class="half_rhythm"><div>Brain MRI for corpus callosum dysgenesis and other neurologic abnormalities</div></li><li class="half_rhythm"><div>Developmental assessment, with further evaluation if significant delays are identified</div></li><li class="half_rhythm"><div>Cardiac evaluation</div></li><li class="half_rhythm"><div>Hearing evaluation, as hearing loss is observed in 8% of cases</div></li><li class="half_rhythm"><div>Consideration of abdominal MRI and standard protocols for management of diaphragmatic hernia</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="microph-lsd.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Under the guidance of an oculoplastics specialist, use of a prosthesis in severe microphthalmia and anophthalmia</div></li><li class="half_rhythm"><div>Regular care by a dermatologist for individuals with significant skin lesions</div></li><li class="half_rhythm"><div>Referral to a pediatric neurologist for evaluation and treatment if microcephaly, seizures, and/or other neurologic abnormalities are present</div></li><li class="half_rhythm"><div>Appropriate developmental therapies and special education as indicated for developmental delay and intellectual disability</div></li><li class="half_rhythm"><div>Standard care for cardiac concerns and other malformations, when present</div></li></ul></div><div id="microph-lsd.Surveillance"><h3>Surveillance</h3><p>Monitoring and follow up with ophthalmologist, dermatologist, pediatric neurologist, and other professionals as needed is appropriate.</p><p>Affected individuals with cardiac concerns should have regular complete evaluation at intervals determined by the cardiologist.</p></div><div id="microph-lsd.Evaluation_of_Relatives_at_R"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#microph-lsd.Related_Genetic_Counseling_I">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="microph-lsd.Therapies_Under_Investigatio"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="microph-lsd.Genetic_Counseling"><h2 id="_microph-lsd_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="microph-lsd.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Microphthalmia with linear skin lesions (MLS) syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner and is generally lethal in males.</p><p>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family).</p></div><div id="microph-lsd.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most females with MLS syndrome have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>In rare cases, a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has inherited an MLS syndrome-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from her mother, who may or may not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> [<a class="bk_pop" href="#microph-lsd.REF.allanson.1991.143">Allanson &#x00026; Richter 1991</a>, <a class="bk_pop" href="#microph-lsd.REF.lindsay.1994.229">Lindsay et al 1994</a>, <a class="bk_pop" href="#microph-lsd.REF.m_cke.1995.197">M&#x000fc;cke et al 1995</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2006.878">Wimplinger et al 2006</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2007a.421">Wimplinger et al 2007a</a>, <a class="bk_pop" href="#microph-lsd.REF.vergult.2013.311">Vergult et al 2013</a>, <a class="bk_pop" href="#microph-lsd.REF.kluger.2014.342">Kluger et al 2014</a>, <a class="bk_pop" href="#microph-lsd.REF.van_rahden.2015.640">van Rahden et al 2015</a>]. Significant intrafamilial phenotypic variability has been observed.</div></li><li class="half_rhythm"><div>Detailed clinical evaluation of the mother and review of the extended family history may help distinguish probands with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from those with an inherited pathogenic variant.</div><ul><li class="half_rhythm"><div>If the mother has clinical findings of MLS syndrome or if she has another <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relative, she is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COX7B</i>, <i>HCCS</i>, or <i>NDUFB11</i>.</div></li><li class="half_rhythm"><div>If a <i>COX7B</i>, <i>HCCS</i>, or <i>NDUFB11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the mother is appropriate to more accurately assess <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs.</div></li></ul></li></ul><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Live-born <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males with MLS syndrome are rare and are the result of a new chromosomal aberration (46,XX <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> and an X/Y <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>).</div></li><li class="half_rhythm"><div>Affected males who do not survive pregnancy may have inherited the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from their mothers or may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother.</p><ul><li class="half_rhythm"><div>If the mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to have a <i>COX7B</i>, <i>HCCS</i>, or <i>NDUFB11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting the pathogenic variant at conception is 50%. Because male conceptuses who inherit such a pathogenic variant are typically nonviable, the likelihood of a live-born affected child is less than 50%.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>COX7B</i>, <i>HCCS</i>, or <i>NDUFB11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to the sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Women with a <i>COX7B</i>, <i>HCCS</i>, or <i>NDUFB11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of transmitting the pathogenic variant to each child.</p><ul><li class="half_rhythm"><div>Males who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, often with lethality during gestation.</div></li><li class="half_rhythm"><div>Females who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be heterozygotes and will have a range of clinical manifestations (see <a href="#microph-lsd.Clinical_Description">Clinical Description</a>).</div></li><li class="half_rhythm"><div>Note: If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is mosaic for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to her offspring is as high as 50%, depending on the level of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in her <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected males are not known to reproduce.</p><p><b>Other family members.</b> If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> also has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, her female family members may be at risk of having the pathogenic variant (and may or may not have clinical findings).</p></div><div id="microph-lsd.Heterozygote_Carrier_Detecti"><h3>Heterozygote (Carrier) Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Note: (1) Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder will have a range of clinical manifestations (see <a href="#microph-lsd.Clinical_Description">Clinical Description</a>). (2) Identification of female heterozygotes requires either (a) prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family or (b) if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> as detailed in <a href="#microph-lsd.Establishing_the_Diagnosis">Establishing the Diagnosis</a>.</p></div><div id="microph-lsd.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of genetic status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or are heterozygotes or who are at increased risk of being heterozygotes or affected.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="microph-lsd.Prenatal_Testing_and_Preimpl"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once a <i>COX7B</i>, <i>HCCS</i>, or <i>NDUFB11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for MLS syndrome are possible.</p></div></div><div id="microph-lsd.Resources"><h2 id="_microph-lsd_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>International Children's Anophthalmia and Microphthalmia Network (ICAN)</b></div><div>c/o Center for Developmental Medicine and Genetics</div><div>5501 Old York Road</div><div>Genetics, Levy 2 West</div><div>Philadelphia PA 19141</div><div><b>Phone:</b> 800-580-4226 (toll-free)</div><div><b>Email:</b> ican@anophthalmia.org</div><div><a href="http://www.anophthalmia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.anophthalmia.org</a></div></li><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/low-vision" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Low Vision</a></div></li><li class="half_rhythm"><div><b>National Federation of the Blind (NFB)</b></div><div>200 East Wells Street</div><div>(at Jernigan Place)</div><div>Baltimore MD 21230</div><div><b>Phone:</b> 410-659-9314</div><div><b>Fax:</b> 410-685-5653</div><div><b>Email:</b> pmaurer@nfb.org</div><div><a href="http://www.nfb.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nfb.org</a></div></li></ul></div><div id="microph-lsd.Molecular_Genetics"><h2 id="_microph-lsd_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="microph-lsd.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Microphthalmia with Linear Skin Defects Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7041/table/microph-lsd.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__microph-lsd.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_microph-lsd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_microph-lsd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_microph-lsd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_microph-lsd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_microph-lsd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_microph-lsd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1349" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COX7B</i></a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1349" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P24311" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cytochrome c oxidase subunit 7B, mitochondrial</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COX7B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COX7B</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COX7B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COX7B</a></td></tr><tr><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3052" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HCCS</i></a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3052" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp22<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P53701" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cytochrome c-type heme lyase</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/HCCS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HCCS @ LOVD</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HCCS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HCCS</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HCCS[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HCCS</a></td></tr><tr><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/54539" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>NDUFB11</i></a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=54539" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp11<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NX14" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NDUFB11" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NDUFB11</a></td><td headers="hd_b_microph-lsd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NDUFB11[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NDUFB11</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="microph-lsd.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="microph-lsd.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Microphthalmia with Linear Skin Defects Syndrome (<a href="/omim/300056,300403,300885,300887,300952,309801" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7041/table/microph-lsd.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__microph-lsd.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300056" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300056</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HOLOCYTOCHROME C SYNTHASE; HCCS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300403" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300403</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 11; NDUFB11</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300885" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300885</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CYTOCHROME c OXIDASE, SUBUNIT 7B; COX7B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300887" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300887</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300952" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300952</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/309801" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">309801</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1</td></tr></tbody></table></div></div><div id="microph-lsd.Introduction"><h3>Introduction</h3><p><i>COX7B</i>, <i>HCCS</i>, and <i>NDUFB11</i> encode proteins necessary for the proper functioning of the mitochondrial respiratory chain (MRC). "Canonic" mitochondrial diseases are usually characterized by postnatal organ failure rather than impaired development: in that regard microphthalmia with linear skin defects (MLS) syndrome can be defined as an unconventional mitochondrial disorder. A combined effect of mitochondrial respiration defects and enhanced cell death are hypothesized to result in the brain and eye abnormalities observed in MLS syndrome.</p><p>The three genes associated with MLS syndrome are all <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>. Females with MLS syndrome show high inter- and intrafamilial phenotypic variability. Individuals can show the full MLS syndrome <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, or they can show <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> ocular manifestations, or aplastic skin areas restricted to face and neck with no additional abnormalities. Females with MLS syndrome may also show no features at all. A possible explanation for this clinical variability is the degree of skewed X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> inactivation observed in different tissues [<a class="bk_pop" href="#microph-lsd.REF.morleo.2008.401">Morleo &#x00026; Franco 2008</a>].</p></div><div id="microph-lsd.COX7B"><h3><i>COX7B</i></h3><p><b>Gene structure.</b>
<i>COX7B</i> (RefSeq: <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001866.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001866.2</a>) has three coding exons. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> spans 5.9 kb, and its transcribed <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> is 456 bp. No information is available on alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>.</p><p><b>Pathogenic variants.</b> The clinically relevant variants reported to date include p.Gln19Ter, c.196delC, and c.41-2A&#x0003e;G [<a class="bk_pop" href="#microph-lsd.REF.indrieri.2012.942">Indrieri et al 2012</a>] (see <a class="figpopup" href="/books/NBK7041/table/microph-lsd.T.cox7b_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figmicrophlsdTcox7bpathogenicvariants" rid-ob="figobmicrophlsdTcox7bpathogenicvariants">Table 3</a>).</p><div id="microph-lsd.T.cox7b_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>COX7B</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7041/table/microph-lsd.T.cox7b_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__microph-lsd.T.cox7b_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.55C&#x0003e;T</td><td headers="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln19Ter</td><td headers="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001866.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001866<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_001857.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001857<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.196delC</td><td headers="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu66CysfsTer48</td></tr><tr><td headers="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.41-2A&#x0003e;G</td><td headers="hd_h_microph-lsd.T.cox7b_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val14GlyfsTer19</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>COX7B</i> is ubiquitously expressed and encodes an 80-amino-acid mitochondrial protein that has been shown to be an integral component of cytochrome <i>c</i> oxidase (COX), the mitochondrial respiratory chain (MRC) complex IV. COX7B subunit is necessary for COX activity, COX assembly, and mitochondrial respiration [<a class="bk_pop" href="#microph-lsd.REF.indrieri.2013.280">Indrieri et al 2013</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Microphthalmia with linear skin defects (MLS) syndrome is caused by pathogenic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>COX7B</i>, which promote severe impairment of the MRC's terminal segment [<a class="bk_pop" href="#microph-lsd.REF.indrieri.2012.942">Indrieri et al 2012</a>]. Moreover, downregulation of the <i>COX7B</i> homolog (<i>cox7B</i>) in medaka fish (<i>Oryzias latipes</i>) results in microcephaly and microphthalmia, thus indicating an essential role for complex IV activity and MRC function in vertebrate CNS development [<a class="bk_pop" href="#microph-lsd.REF.indrieri.2013.280">Indrieri et al 2013</a>].</p></div><div id="microph-lsd.HCCS"><h3><i>HCCS</i></h3><p><b>Gene structure.</b>
<i>HCCS</i> has seven exons, six of which are coding exons. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> spans 11.8 kb, and its transcribed <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> is long at 2,365 bp. No information on alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> for this transcript is available (see <a class="figpopup" href="/books/NBK7041/table/microph-lsd.T.hccs_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figmicrophlsdThccspathogenicvariantsd" rid-ob="figobmicrophlsdThccspathogenicvariantsd">Table 4</a>). For a detailed summary of gene and protein information, see <a href="/books/NBK7041/#microph-lsd.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The majority of <i>HCCS</i> disease-causing aberrations are large deletions involving the Xp22.2 <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region [<a class="bk_pop" href="#microph-lsd.REF.vergult.2013.311">Vergult et al 2013</a>]; other reported pathogenic variants include p.Arg197Ter, p.Arg217Cys, and p.Glu159Lys, and a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of exons 1-3 [<a class="bk_pop" href="#microph-lsd.REF.wimplinger.2006.878">Wimplinger et al 2006</a>, <a class="bk_pop" href="#microph-lsd.REF.wimplinger.2007b.1475">Wimplinger et al 2007b</a>] (see <a class="figpopup" href="/books/NBK7041/table/microph-lsd.T.hccs_pathogenic_variants_d/?report=objectonly" target="object" rid-figpopup="figmicrophlsdThccspathogenicvariantsd" rid-ob="figobmicrophlsdThccspathogenicvariantsd">Table 4</a>).</p><div id="microph-lsd.T.hccs_pathogenic_variants_d" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>HCCS</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7041/table/microph-lsd.T.hccs_pathogenic_variants_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__microph-lsd.T.hccs_pathogenic_variants_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.589C&#x0003e;T</td><td headers="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg197Ter</td><td headers="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_005333" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005333<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_005324.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005324<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.649C&#x0003e;T</td><td headers="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg217Cys</td></tr><tr><td headers="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.475G&#x0003e;A</td><td headers="hd_h_microph-lsd.T.hccs_pathogenic_variants_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu159Lys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>HCCS</i> is expressed in a wide variety of tissues and encodes a mitochondrial enzyme of 268 amino acids, the holocytochrome <i>c-</i>type synthase, which catalyzes the covalent attachment of heme to apocytochrome <i>c</i>, thereby leading to the mature form holocytochrome <i>c</i> [<a class="bk_pop" href="#microph-lsd.REF.bernard.2003.49732">Bernard et al 2003</a>].</p><p>The product of the HCCS-catalyzed reaction, cytochrome <i>c</i>, has two cellular functions: it is implicated in oxidative phosphorylation (OXPHOS), and it is released from mitochondria upon proapoptotic stimuli, thus playing an important role in caspase-dependent apoptosis [<a class="bk_pop" href="#microph-lsd.REF.jiang.2004.87">Jiang &#x00026; Wang 2004</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> MLS syndrome is caused by pathogenic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>HCCS</i>. Recently it was hypothesized that deficiency of HCCS may not only cause functional deficits in OXPHOS, but may also lead to severe constraints in the process of apoptosis. Thus, loss of HCCS function may disturb the balance between necrosis and apoptosis and push cell death toward necrosis [<a class="bk_pop" href="#microph-lsd.REF.wimplinger.2006.878">Wimplinger et al 2006</a>]. Necrosis bears the danger of inflammatory reactions, leading to substantial damage of neighboring cells that could be a key element in developing eye malformations as well as other MLS syndrome-specific features in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="microph-lsd.NDUFB11"><h3><i>NDUFB11</i></h3><p><b>Gene structure.</b>
<i>NDUFB11</i> spans 3 kb; its transcribed <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> is 2,365 bp long. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> comprises three exons; <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 is alternatively spliced [<a class="bk_pop" href="#microph-lsd.REF.petruzzella.2007.181">Petruzzella et al 2007</a>].</p><p><b>Pathogenic variants.</b> Reported pathogenic variants include p.Arg88Ter and c.402delG [<a class="bk_pop" href="#microph-lsd.REF.van_rahden.2015.640">van Rahden et al 2015</a>].</p><div id="microph-lsd.T.ndufb11_pathogenic_variant" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>NDUFB11</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7041/table/microph-lsd.T.ndufb11_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__microph-lsd.T.ndufb11_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_microph-lsd.T.ndufb11_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_microph-lsd.T.ndufb11_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_microph-lsd.T.ndufb11_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_microph-lsd.T.ndufb11_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.262C&#x0003e;T</td><td headers="hd_h_microph-lsd.T.ndufb11_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg88Ter</td><td headers="hd_h_microph-lsd.T.ndufb11_pathogenic_variant_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_019056.6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_019056<wbr style="display:inline-block"></wbr>​.6</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_061929.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_061929<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_microph-lsd.T.ndufb11_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.402delG</td><td headers="hd_h_microph-lsd.T.ndufb11_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg134SerfsTer3</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein encoded by <i>NDUFB11</i> is the 17.3-kd subunit 11 of the NADH dehydrogenase (ubiquinone) 1 beta subcomplex and is part of the MRC complex I (cI). The longer transcript encodes a 163-amino-acid (aa) protein, while the shorter one encodes a more abundant protein consisting of 153 aa. The NDUFB11 protein is indispensable for assembly of the cI membrane arm, for maturation of the cI holocomplex, and for cI-dependent mitochondrial respiration.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> MLS syndrome is caused by pathogenic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>NDUFB11</i>, resulting in defective cI assembly and activity leading to impairment of mitochondrial respiration [<a class="bk_pop" href="#microph-lsd.REF.van_rahden.2015.640">van Rahden et al 2015</a>]. Moreover, reduced NDUFB11 is associated with slower cell growth and increased apoptosis [<a class="bk_pop" href="#microph-lsd.REF.van_rahden.2015.640">van Rahden et al 2015</a>].</p><p>A combined effect of MRC defects and enhanced cell death has been shown to underlie the brain and eye abnormalities observed in an hccs-deficient medaka fish model [<a class="bk_pop" href="#microph-lsd.REF.indrieri.2013.280">Indrieri et al 2013</a>].</p></div></div><div id="microph-lsd.References"><h2 id="_microph-lsd_References_">References</h2><div id="microph-lsd.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.alberry.2011.111">Alberry MS, Juvanic G, Crolla J, Soothill P, Newbury-Ecob R. Pseudotail as a feature of microphthalmia with linear skin defects syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2011;<span class="ref-vol">20</span>:111–3.</span> [<a href="/pubmed/21200317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21200317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.algazali.1990.59">al-Gazali LI, Mueller RF, Caine A, Antoniou A, McCartney A, Fitchett M, Dennis NR. Two 46,XX,t(X;Y) females with linear skin defects and congenital microphthalmia: a new syndrome at Xp22.3. <span><span class="ref-journal">J Med Genet. </span>1990;<span class="ref-vol">27</span>:59–63.</span> [<a href="/pmc/articles/PMC1016884/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016884</span></a>] [<a href="/pubmed/2308157" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2308157</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.allanson.1991.143">Allanson J, Richter S. Linear skin defects and congenital microphthalmia: a new syndrome at Xp22.2. <span><span class="ref-journal">J Med Genet. </span>1991;<span class="ref-vol">28</span>:143–4.</span> [<a href="/pmc/articles/PMC1016789/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016789</span></a>] [<a href="/pubmed/2002490" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2002490</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.anguiano.2003.47">Anguiano A, Yang X, Felix JK, Hoo JJ. Twin brothers with MIDAS syndrome and XX karyotype. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">119A</span>:47–9.</span> [<a href="/pubmed/12707958" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12707958</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.bernard.2003.49732">Bernard DG, Gabilly ST, Dujardin G, Merchant S, Hamel PP. Overlapping specificities of the mitochondrial cytochrome c and c1 heme lyases. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:49732–42.</span> [<a href="/pubmed/14514677" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14514677</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.bird.1994.141">Bird LM, Krous HF, Eichenfield LF, Swalwell CI, Jones MC. Female infant with oncocytic cardiomyopathy and microphthalmia with linear skin defects (MLS): a clue to the pathogenesis of oncocytic cardiomyopathy? <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">53</span>:141–8.</span> [<a href="/pubmed/7856638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7856638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.cain.2007.373">Cain CC, Saul D, Attanasio L, Oehler E, Hamosh A, Blakemore K, Stetten G. Microphthalmia with linear skin defects (MLS) syndrome evaluated by prenatal karyotyping, FISH and array comparative genomic hybridization. <span><span class="ref-journal">Prenat Diagn. </span>2007;<span class="ref-vol">27</span>:373–9.</span> [<a href="/pubmed/17286317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17286317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.cape.2004.1070">Cape CJ, Zaidman GW, Beck AD, Kaufman AH. Phenotypic variation in ophthalmic manifestations of MIDAS syndrome (microphthalmia, dermal aplasia, and sclerocornea). <span><span class="ref-journal">Arch Ophthalmol. </span>2004;<span class="ref-vol">122</span>:1070–4.</span> [<a href="/pubmed/15249380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15249380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.carman.2009.234">Carman KB, Yakut A, Sabuncu I, Yarar C. MIDAS (microphthalmia, dermal aplasia, sclerocornea) syndrome with central nervous system abnormalities. <span><span class="ref-journal">Clin Dysmorphol. </span>2009;<span class="ref-vol">18</span>:234–5.</span> [<a href="/pubmed/19726975" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19726975</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.eng.1994.680">Eng A, Lebel RR, Elejalde BR, Anderson C, Bennett L. Linear facial skin defects associated with microphthalmia and other malformations, with chromosome deletion Xp22.1. <span><span class="ref-journal">J Am Acad Dermatol. </span>1994;<span class="ref-vol">31</span>:680–2.</span> [<a href="/pubmed/8089303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8089303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.enright.2003.153">Enright F, Campbell P, Stallings RL, Hall K, Green AJ, Sweeney E, Barnes L, Watson R. Xp22.3 microdeletion in a 19-year-old girl with clinical features of MLS syndrome. <span><span class="ref-journal">Pediatr Dermatol. </span>2003;<span class="ref-vol">20</span>:153–7.</span> [<a href="/pubmed/12657015" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12657015</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.garc_arabasco.2013.e230">Garc&#x000ed;a-Rabasco A, De-Unamuno B, Mart&#x000ed;nez F, Febrer-Bosch I, Alegre-de-Miquel V. Microphtalmia with linear skin defects syndrome. <span><span class="ref-journal">Pediatr Dermatol. </span>2013;<span class="ref-vol">30</span>:e230–31.</span> [<a href="/pubmed/22612277" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22612277</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.happle.1993.710">Happle R, Dani&#x000eb;ls O, Koopman RJ. MIDAS syndrome (microphthalmia, dermal aplasia, and sclerocornea): an X-linked phenotype distinct from Goltz syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">47</span>:710–3.</span> [<a href="/pubmed/8267001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8267001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.herwig.2014.491">Herwig MC, Loeffler KU, Gembruch U, Kuchelmeister K, M&#x000fc;ller AM. Anterior Segment Developmental Anomalies in a 33-Week-Old Fetus with MIDAS Syndrome. <span><span class="ref-journal">Pediatr Dev Pathol. </span>2014;<span class="ref-vol">17</span>:491–5.</span> [<a href="/pubmed/25291437" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25291437</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.hobson.2009.1698">Hobson GM, Gibson CW, Aragon M, Yuan ZA, Davis-Williams A, Banser L, Kirkham J, Brook AH. A large X-chromosomal deletion is associated with microphthalmia with linear skin defects (MLS) and amelogenesis imperfecta (XAI). <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:1698–705.</span> [<a href="/pmc/articles/PMC2760392/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2760392</span></a>] [<a href="/pubmed/19610109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19610109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.indrieri.2012.942">Indrieri A, van Rahden VA, Tiranti V, Morleo M, Iaconis D, Tammaro R, D'Amato I, Conte I, Maystadt I, Demuth S, Zvulunov A, Kutsche K, Zeviani M, Franco B. Mutations in COX7B cause microphthalmia with linear skin lesions, an unconventional mitochondrial disease. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:942–49.</span> [<a href="/pmc/articles/PMC3487127/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3487127</span></a>] [<a href="/pubmed/23122588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23122588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.indrieri.2013.280">Indrieri A, Conte I, Chesi G, Romano A, Quartararo J, Tate R, Ghezzi D, Zeviani M, Goffrini P, Ferrero I, Bovolenta P, Franco B. The impairment of HCCS leads to MLS syndrome by activating a non-canonical cell death pathway in the brain and eyes. <span><span class="ref-journal">EMBO Mol Med. </span>2013;<span class="ref-vol">5</span>:280–93.</span> [<a href="/pmc/articles/PMC3569643/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3569643</span></a>] [<a href="/pubmed/23239471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23239471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.jiang.2004.87">Jiang X, Wang X. Cytochrome C-mediated apoptosis. <span><span class="ref-journal">Annu Rev Biochem. </span>2004;<span class="ref-vol">73</span>:87–106.</span> [<a href="/pubmed/15189137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15189137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.kapur.2008.734">Kapur R, Tu EY, Toyran S, Shah P, Vangveeravong S, Lloyd WC 3rd, Edward DP. Corneal pathology in microphthalmia with linear skin defects syndrome. <span><span class="ref-journal">Cornea. </span>2008;<span class="ref-vol">27</span>:734–8.</span> [<a href="/pubmed/18580270" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18580270</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.kherbaouiredouani.2003.224">Kherbaoui-Redouani L, Eschard C, Bednarek N, Morville P, Bednare N. Cutaneous aplasia, non compaction of the left ventricle and severe cardiac arrhythmia: a new case of MLS syndrome (microphtalmia with linear skin defects). <span><span class="ref-journal">Arch Pediatr. </span>2003;<span class="ref-vol">10</span>:224–6.</span> [<a href="/pubmed/12829336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12829336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.kluger.2014.342">Kluger N, Bouissou A, Tauzin L, Puechberty J, Dereure O. Congenital linear streaks on the face and neck and microphthalmia in an infant girl. <span><span class="ref-journal">Acta Derm Venereol. </span>2014;<span class="ref-vol">94</span>:342–3.</span> [<a href="/pubmed/24096629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24096629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.kobayashi.1998.122">Kobayashi M, Kiyosawa M, Toyoura T, Tokoro T. An XX male with microphthalmos and sclerocornea. <span><span class="ref-journal">J Pediatr Ophthalmol Strabismus. </span>1998;<span class="ref-vol">35</span>:122–4.</span> [<a href="/pubmed/9559515" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9559515</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.kono.1999.63">Kono T, Migita T, Koyama S, Seki I. Another observation of microphthalmia in an XX male: microphthalmia with linear skin defects syndrome without linear skin lesions. <span><span class="ref-journal">J Hum Genet. </span>1999;<span class="ref-vol">44</span>:63–8.</span> [<a href="/pubmed/9929982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9929982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.lindsay.1994.229">Lindsay EA, Grillo A, Ferrero GB, Roth EJ, Magenis E, Grompe M, Hult&#x000e9;n M, Gould C, Baldini A, Zoghbi HY, Ballabio A. Microphthalmia with linear skin defects (MLS) syndrome: clinical, cytogenetic and molecular characterization. <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">49</span>:229–34.</span> [<a href="/pubmed/8116674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8116674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.morleo.2008.401">Morleo M, Franco B. Dosage compensation of the mammalian X chromosome influences the phenotypic variability of X-linked dominant male-lethal disorders. <span><span class="ref-journal">J Med Genet. </span>2008;<span class="ref-vol">45</span>:401–8.</span> [<a href="/pubmed/18463129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18463129</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.morleo.2005.190">Morleo M, Pramparo T, Perone L, Gregato G, Le Caignec C, Mueller RF, Ogata T, Raas-Rothschild A, de Blois MC, Wilson LC, Zaidman G, Zuffardi O, Ballabio A, Franco B. Microphthalmia with linear skin defects (MLS) syndrome: clinical, cytogenetic, and molecular characterization of 11 cases. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">137</span>:190–8.</span> [<a href="/pubmed/16059943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16059943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.m_cke.1995.197">M&#x000fc;cke J, Hoepffner W, Thamm B, Theile H. MIDAS syndrome (microphthalmia, dermal aplasia and sclerocornea): an autonomous entity with linear skin defects within the spectrum of focal hypoplasias. <span><span class="ref-journal">Eur J Dermatol. </span>1995;<span class="ref-vol">5</span>:197–203.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.paulger.1997.26">Paulger BR, Kraus EW, Pulitzer DR, Moore CM. Xp microdeletion syndrome characterized by pathognomonic linear skin defects on the head and neck. <span><span class="ref-journal">Pediatr Dermatol. </span>1997;<span class="ref-vol">14</span>:26–30.</span> [<a href="/pubmed/9050760" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9050760</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.petruzzella.2007.181">Petruzzella V, Tessa A, Torraco A, Fattori F, Dotti MT, Bruno C, Cardaioli E, Papa S, Federico A, Santorelli FM. The NDUFB11 gene is not a modifier in Leber hereditary optic neuropathy. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2007;<span class="ref-vol">355</span>:181–7.</span> [<a href="/pubmed/17292333" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17292333</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.rea.2017.a001271">Rea G, Homfray T, Till J, Roses-Noguer F, Buchan RJ, Wilkinson S, Wilk A, Walsh R, John S, McKee S, Stewart FJ, Murday V, Taylor RW, Ashworth M, Baksi AJ, Daubeney P, Prasad S, Barton PJR, Cook SA, Ware JS. Histiocytoid cardiomyopathy and microphthalmia with linear skin defects syndrome: phenotypes linked by truncating variants in <em>NDUFB11</em>. <span><span class="ref-journal">Cold Spring Harb Mol Case Stud. </span>2017;<span class="ref-vol">3</span>:a001271.</span> [<a href="/pmc/articles/PMC5171697/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5171697</span></a>] [<a href="/pubmed/28050600" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28050600</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.schluth.2007.29">Schluth C, Cossee M, Girard-Lemaire F, Carelle N, Dollfus H, Jeandidier E, Flori E. Phenotype in X chromosome rearrangements: pitfalls of X inactivation study. <span><span class="ref-journal">Pathol Biol (Paris). </span>2007;<span class="ref-vol">55</span>:29–36.</span> [<a href="/pubmed/16690229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16690229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.sharma.2008.548">Sharma VM, Ruiz de Luzuriaga AM, Waggoner D, Greenwald M, Stein SL. Microphthalmia with linear skin defects: a case report and review. <span><span class="ref-journal">Pediatr Dermatol. </span>2008;<span class="ref-vol">25</span>:548–52.</span> [<a href="/pubmed/18950397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18950397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.shehata.2015.2114">Shehata BM, Cundiff CA, Lee K, Sabharwal A, Lalwani MK, Davis AK, Agrawal V, Sivasubbu S, Iannucci GJ, Gibson G. Exome sequencing of patients with histiocytoid cardiomyopathy reveals a de novo NDUFB11 mutation that plays a role in the pathogenesis of histiocytoid cardiomyopathy. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2114–21.</span> [<a href="/pmc/articles/PMC4753789/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4753789</span></a>] [<a href="/pubmed/25921236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25921236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.steichengersdorf.2010.82">Steichen-Gersdorf E, Griesmaier E, Pientka FK, Kotzot D, Kutsche K. A severe form of the X-linked microphthalmia with linear skin defects syndrome in a female newborn. <span><span class="ref-journal">Clin Dysmorphol. </span>2010;<span class="ref-vol">19</span>:82–4.</span> [<a href="/pubmed/20179582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20179582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.stratton.1998.37">Stratton RF, Walter CA, Paulgar BR, Price ME, Moore CM. Second 46,XX males with MLS syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">76</span>:37–41.</span> [<a href="/pubmed/9508062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9508062</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.torraco.2017.441">Torraco A, Bianchi M, Verrigni D, Gelmetti V, Riley L, Niceta M, Martinelli D, Montanari A, Guo Y, Rizza T, Diodato D, Di Nottia M, Lucarelli B, Sorrentino F, Piemonte F, Francisci S, Tartaglia M, Valente EM, Dionisi-Vici C, Christodoulou J, Bertini E, Carrozzo R. A novel mutation in NDUFB11 unveils a new clinical phenotype associated with lactic acidosis and sideroblastic anemia. <span><span class="ref-journal">Clin Genet. </span>2017;<span class="ref-vol">91</span>:441–47.</span> [<a href="/pubmed/27102574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27102574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.van_rahden.2014.53">van Rahden VA, Rau I, Fuchs S, Kosyna FK, Larangeira de Almeida H Jr, Fryssira F, Isidor B, Jauch A, Joubert M, Lachmeijer AMA, Zweier C, Moog U, Kutsche K. Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:53.</span> [<a href="/pmc/articles/PMC4021606/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4021606</span></a>] [<a href="/pubmed/24735900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24735900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.van_rahden.2015.640">van Rahden VA, Fernandez-Vizarra E, Alawi M, Brand K, Florence Fellmann F, Horn D, Massimo Zeviani Z, Kutsche K. Mutations in NDUFB11, Encoding a complex I component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">96</span>:640–50.</span> [<a href="/pmc/articles/PMC4385192/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4385192</span></a>] [<a href="/pubmed/25772934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25772934</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.vergult.2013.311">Vergult S, Leroy B, Claerhout I, Menten B. Familial cases of a submicroscopic Xp22.2 deletion: genotype-phenotype correlation in microphthalmia with linear skin defects syndrome. <span><span class="ref-journal">Mol Vis. </span>2013;<span class="ref-vol">19</span>:311–8.</span> [<a href="/pmc/articles/PMC3566894/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3566894</span></a>] [<a href="/pubmed/23401659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23401659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.wimplinger.2006.878">Wimplinger I, Morleo M, Rosenberger G, Iaconis D, Orth U, Meinecke P, Lerer I, Ballabio A, Gal A, Franco B, Kutsche K. Mutations of the mitochondrial holocytochrome c-type synthase in X-linked dominant microphthalmia with linear skin defects syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">79</span>:878–89.</span> [<a href="/pmc/articles/PMC1698567/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1698567</span></a>] [<a href="/pubmed/17033964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17033964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.wimplinger.2007a.421">Wimplinger I, Rauch A, Orth U, Schwarzer U, Trautmann U, Kutsche K. Mother and daughter with a terminal Xp deletion: implication of chromosomal mosaicism and X-inactivation in the high clinical variability of the microphthalmia with linear skin defects (MLS) syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2007a;<span class="ref-vol">50</span>:421–31.</span> [<a href="/pubmed/17845869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17845869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.wimplinger.2007b.1475">Wimplinger I, Shaw GM, Kutsche K. HCCS loss-of-function missense mutation in a female with bilateral microphthalmia and sclerocornea: a novel gene for severe ocular malformations? <span><span class="ref-journal">Mol Vis. </span>2007b;<span class="ref-vol">13</span>:1475–82.</span> [<a href="/pubmed/17893649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17893649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="microph-lsd.REF.zvulunov.1998.1046">Zvulunov A, Kachko L, Manor E, Shinwell E, Carmi R. Reticulolinear aplasia cutis congenita of the face and neck: a distinctiv cutaneous manifestation in several syndromes linked to Xp22. <span><span class="ref-journal">Br J Dermatol. </span>1998;<span class="ref-vol">138</span>:1046–52.</span> [<a href="/pubmed/9747372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9747372</span></a>]</div></li></ul></div></div><div id="microph-lsd.Chapter_Notes"><h2 id="_microph-lsd_Chapter_Notes_">Chapter Notes</h2><div id="microph-lsd.Acknowledgments"><h3>Acknowledgments</h3><p>Research by the authors is supported by the Italian Telethon Foundation. We thank the families and all individuals <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with MLS syndrome participating in our research programs.</p></div><div id="microph-lsd.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>26 July 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 August 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 September 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically; <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> no longer available</div></li><li class="half_rhythm"><div>18 June 2009 (et) Review posted live</div></li><li class="half_rhythm"><div>16 January 2009 (mm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK7041</span><span class="label">PMID: <a href="/pubmed/20301767" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301767</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/miccap-ms/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/anophthalmia-ov/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK7041&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK7041/?report=reader">PubReader</a></li><li><a href="/books/NBK7041/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK7041" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK7041" style="display:none" title="Cite this Page"><div class="bk_tt">Morleo M, Franco B. Microphthalmia with Linear Skin Defects Syndrome. 2009 Jun 18 [Updated 2018 Jul 26]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK7041/pdf/Bookshelf_NBK7041.pdf">PDF version of this page</a> (757K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#microph-lsd.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#microph-lsd.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#microph-lsd.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#microph-lsd.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#microph-lsd.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#microph-lsd.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#microph-lsd.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#microph-lsd.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#microph-lsd.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#microph-lsd.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#microph-lsd.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1349[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COX7B</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3052[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HCCS</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=54539[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NDUFB11</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK7041+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1533136" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1533136" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1533136" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1533136" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301712" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Focal Dermal Hypoplasia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Focal Dermal Hypoplasia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bostwick B, Van den Veyver IB, Sutton VR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25772934" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mutations in NDUFB11, encoding a complex I component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome.</a><span class="source">[Am J Hum Genet. 2015]</span><div class="brieflinkpop offscreen_noflow">Mutations in NDUFB11, encoding a complex I component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van Rahden VA, Fernandez-Vizarra E, Alawi M, Brand K, Fellmann F, Horn D, Zeviani M, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2015 Apr 2; 96(4):640-50. Epub 2015 Mar 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24735900" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome.</a><span class="source">[Orphanet J Rare Dis. 2014]</span><div class="brieflinkpop offscreen_noflow">Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van Rahden VA, Rau I, Fuchs S, Kosyna FK, de Almeida HL Jr, Fryssira H, Isidor B, Jauch A, Joubert M, Lachmeijer AM, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2014 Apr 15; 9:53. Epub 2014 Apr 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301694" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lenz Microphthalmia Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lenz Microphthalmia Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ng D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301534" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moosajee M, Hingorani M, Moore AT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301767" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301767" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc9062dd21425a2559e0ae">Microphthalmia with Linear Skin Defects Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Microphthalmia with Linear Skin Defects Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:12:02-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D1B67DFC88DC100000000039901B1&amp;ncbi_session=CE8D1B67DFC90621_0921SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK7041%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK7041&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK7041/&amp;ncbi_pagename=Microphthalmia with Linear Skin Defects Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D1B67DFC90621_0921SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>